From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC)
Article in Diagnostics (December 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Diagnostics (December 2023)
Article in Reactions Weekly (March 2023)